Jump to Navigation

Facebook Connect

User login

NLA Journal Club

 FOURIER trial: Understanding the Role of PCSK9 Inhibitors in ASCVD Patients​

Presented by Daniel Soffer, MD, FNLA, FACP and Alan S. Brown, MD, FACC, FAHA, FNLA, FASPC

No votes yet
Publish Date: 
Friday, May 19, 2017 - 15:30

by Dr. Radut.